Current ASCIA Action Plans are the 2021 versions, however, the 2020 and 2018 versions are still valid for use throughout 2021, or until the review date on the plan. ASCIA Action Plans do not expire, and therefore the plan is still valid beyond the date of review, which is a guide for patients to see their doctor. For further information about ASCIA Action Plans go to www.allergy.org.au/hp/anaphylaxis/action-plans-for-allergic-reactions-faq
This plan is provided to people with allergies who have been prescribed EpiPen® adrenaline injectors.
This plan is provided to people with allergies who have been prescribed Anapen® adrenaline injectors.
This plan is provided to people with allergies who have been prescribed any brand of adrenaline injectors.
This document can be printed as a poster, and used with the generic versions of ASCIA Action Plans or First Aid Plans for Anaphylaxis
This plan is provided to people with allergies who have not been prescribed adrenaline autoinjector/s.
An ASCIA Action Plan for Anaphylaxis for use with adrenaline autoinjectors on airlines is available upon request. This plan is should be stored with adrenaline autoinjectors in emergency medical kits on airlines.
Note: These have replaced the general versions of ASCIA Action Plans for Anaphylaxis (ORANGE)
This plan can be used as a poster or stored with general use EpiPen® adrenaline autoinjectors.
This plan can be used as a poster or stored with general use Anapen® adrenaline autoinjectors.
This plan can be used as a poster or stored with general use adrenaline autoinjectors.
The ASCIA Action Plan is best viewed when printed as an A3 poster.
For translated versions of ASCIA First Aid for Anaphylaxis go to www.allergy.org.au/hp/anaphylaxis#ta5
For further information about ASCIA Action Plans and other anaphylaxis resources go to www.allergy.org.au/anaphylaxis
Content updated June 2021
Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases